✦ LIBER ✦

P.2.b.013 A comparison of the pharmacokinetics of venlafaxine extended release and desvenlafaxine succinate in healthy subjects

✍ Scribed by S. Preskorn; A. Patroneva; A. Nichols; H. Silman; R. Pedersen; J. Paul; S. Ahmed

Book ID: 118593918
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 57 KB
Volume: 17
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(07)70490-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of Venlafaxine Extended

Pharmacokinetics of Venlafaxine Extended Release 75 mg and Desvenlafaxine 50 mg in Healthy CYP2D6 Extensive and Poor Metabolizers

✍ Dr Alice I. Nichols, Kristen Focht, Qin Jiang, Sheldon H. Preskorn, Cecelia P. K 📂 Article 📅 2011 🏛 Springer International Publishing AG 🌐 English ⚖ 172 KB

P.2.d.015 The effects of desvenlafaxine

P.2.d.015 The effects of desvenlafaxine succinate and paroxetine on the pharmacokinetics of desipiramine in healthy adults

✍ A. Patroneva; A.I. Nichols; P. Fatato; M. Shenouda; J. Paul; R.D. Pedersen; Q. J 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB

P.2.c.007 Comparison of bupropion extend

P.2.c.007 Comparison of bupropion extended release and venlafaxine extended release for the treatment of depression: a double-blind, multicentre trial

✍ A.H. Clayton; M.E. Thase; B.R. Haight; A.E. Harriett; N.E. Richard; E.P. Goodale 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB

P01-79 - Pet-measured occupancy of the D

P01-79 - Pet-measured occupancy of the D2 receptor: a comparison of quetiapine fumarate immediate-and extended-release formulations in healthy subjects

✍ S. Nyberg 📂 Article 📅 2010 🏛 Elsevier Science 🌐 French ⚖ 27 KB

P.2.c.037 Assessing the pharmacokinetics

P.2.c.037 Assessing the pharmacokinetics of venlafaxine er 75 mg and desvenlafaxine 50 mg in CYP2D6 extensive and poor metabolisers

✍ C. Kane; A. Nichols; K. Focht; Q. Jiang; S. Preskorn; M. Burczynski 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 107 KB

P0586 A COMPARISON OF THE SINGLE-DOSE PH

P0586 A COMPARISON OF THE SINGLE-DOSE PHARMACOKINETICS AND SAFETY OF SAXAGLIPTIN IN SUBJECTS WITH HEPATIC IMPAIRMENT AND IN HEALTHY SUBJECTS

✍ David W Boulton; Angela Tang; Chirag Patel; Lorna Castaneda; Uli Frevert; Li Li; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 74 KB